Impact of CYP2C19 metabolizer status on esophageal mucosal inflammation, acid exposure, and motility among patients on chronic proton-pump inhibitor therapy with refractory symptoms of gastroesophageal reflux disease.
Saved in:
| Title: | Impact of CYP2C19 metabolizer status on esophageal mucosal inflammation, acid exposure, and motility among patients on chronic proton-pump inhibitor therapy with refractory symptoms of gastroesophageal reflux disease. |
|---|---|
| Authors: | Tai CC; Department of Medicine, Schulich School of Medicine & Dentistry, Western University, London, ON N6A 5C1, Canada., Medwid S; Department of Medicine, Schulich School of Medicine & Dentistry, Western University, London, ON N6A 5C1, Canada.; Division of Clinical Pharmacology, Department of Medicine, Schulich School of Medicine and Dentistry, Western University, London, ON N6A 5C1, Canada., Mclntosh K; Department of Medicine, Schulich School of Medicine & Dentistry, Western University, London, ON N6A 5C1, Canada.; Division of Gastroenterology, Department of Medicine, Schulich School of Medicine & Dentistry, Western University, London, ON N6A 5C1, Canada., Chande N; Department of Medicine, Schulich School of Medicine & Dentistry, Western University, London, ON N6A 5C1, Canada.; Division of Gastroenterology, Department of Medicine, Schulich School of Medicine & Dentistry, Western University, London, ON N6A 5C1, Canada., Kim RB; Department of Medicine, Schulich School of Medicine & Dentistry, Western University, London, ON N6A 5C1, Canada.; Division of Clinical Pharmacology, Department of Medicine, Schulich School of Medicine and Dentistry, Western University, London, ON N6A 5C1, Canada., Gregor J; Department of Medicine, Schulich School of Medicine & Dentistry, Western University, London, ON N6A 5C1, Canada.; Division of Gastroenterology, Department of Medicine, Schulich School of Medicine & Dentistry, Western University, London, ON N6A 5C1, Canada. |
| Source: | Journal of the Canadian Association of Gastroenterology [J Can Assoc Gastroenterol] 2024 Feb 10; Vol. 7 (3), pp. 238-245. Date of Electronic Publication: 2024 Feb 10 (Print Publication: 2024). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Oxford University Press Country of Publication: England NLM ID: 101738684 Publication Model: eCollection Cited Medium: Internet ISSN: 2515-2092 (Electronic) Linking ISSN: 25152084 NLM ISO Abbreviation: J Can Assoc Gastroenterol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2515-2092 |
|---|---|
| DOI: | 10.1093/jcag/gwae005 |
